New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents. What do we know about this phenomenon, and how serious is it? We talk to Dr. Robert McDonald, PhD, of the Mayo Clinic in Rochester, MN.
Video Interview 2018 RSNA
Video from RSNA 2018: What do we know about gadolinium deposition?
Nov 26, 2018
Latest in MRI
GE HealthCare secures FDA clearances for Signa MRI tech
February 19, 2026
Cardiac MRI-based ML model predicts MACE risk for STEMI patients
February 17, 2026
3D MRI technique helps plan treatment for pediatric heart conditions
February 12, 2026
Siemens Healthineers, Mayo Clinic expand collaboration
February 12, 2026
